Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer
1 other identifier
interventional
24
1 country
1
Brief Summary
This study examines the feasibility and acceptability of an open trial of mindfulness-based Cognitive Behavioral Therapy intervention delivered via telephone to men and women age 21 and older with a diagnosis of advanced cancer. Potential participants (N=35) will be recruited via letter from their oncologist at community-based clinics (N=18) and those served at the Duke Cancer Institute in Durham who live more than 60 miles away (N=17). Following informed consent, participants will be asked to complete assessments (e..g., examining their pain, anxiety, depression, fatigue, and engagement in valued activity). They will then receive 4 weekly 50-minute telephone sessions with a study therapist and practice skills learned in session at home. After completing the 4 sessions, they will complete a post-treatment assessment. Data analyses will examine the feasibility and acceptability of the study by assessing participant engagement, and will examine changes in key psychological variables (e.g., pain, anxiety, depression, fatigue, and valued activity) from baseline to post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2017
CompletedFirst Posted
Study publicly available on registry
September 18, 2017
CompletedStudy Start
First participant enrolled
January 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2018
CompletedAugust 19, 2019
August 1, 2019
8 months
September 14, 2017
August 15, 2019
Conditions
Outcome Measures
Primary Outcomes (4)
Feasibility as measured by study attrition which will be assessed by patients who do not complete the post-assessment.
Feasibility will be shown by no more than 20% study attrition.
8 weeks
Acceptability, as measured by Client Satisfaction Questionnaire 10-item version
Acceptability will be indicated by at least 80% of the participants reporting satisfaction with the CBT protocol (mean score of 7) on the CSQ
8 weeks
Feasibility as measured by study accrual by meeting recruitment goal
Feasibility will be shown by meeting targeted study accrual (N=35) in the 12-month study period.
8 weeks
Feasibility as measured by adherence to the study protocol by number of intervention sessions completed by the participant
Feasibility will be shown by adherence to at least 75% of the intervention sessions (3/4)
8 weeks
Secondary Outcomes (6)
Change in pain
Baseline and 8 weeks
Change in fatigue
Baseline and 8 weeks
Change in depression
Baseline and 8 weeks
Change in Mindfulness
Baseline and 8 weeks
Change in anxiety
Baseline and 8 weeks
- +1 more secondary outcomes
Study Arms (1)
Cognitive Behavioral Mutli-Symptom management(CBT)
OTHERLearn to manage distress, fatigue, and/or pain via Cognitive Behavioral Multi-Symptom Management(CBT). Four sessions will be conducted each session is approximately one hour.
Interventions
Learn to manage distress, fatigue, and/or pain via (Cognitive Behavioral Multi-Symptom management (CBT) four one hour sessions.
Eligibility Criteria
You may qualify if:
- being at least 21 years of age
- a diagnosis of stage IV cancer in the past 3 years
- being able to speak/read English
You may not qualify if:
- visual or hearing impairment that would prevent ability to engage in the telephone session or study materials
- presence of a severe unmanaged psychiatric condition (i.e., psychotic disorder or episode) or a psychiatric condition (e.g., suicidal intent) that would contraindicate safe participation in the study as indicated by the medical chart, treating oncologist, or interactions with the medical/study staff.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Palliative Care Research Cooperative Groupcollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27705, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Plumb Vilardaga
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2017
First Posted
September 18, 2017
Study Start
January 3, 2018
Primary Completion
September 8, 2018
Study Completion
September 8, 2018
Last Updated
August 19, 2019
Record last verified: 2019-08